Product Details

Latest Guide to Chinese Pharmaceutical GMP Regulations

Published: August 2012 | Pages: 136 | Price: $750 | Table of Contents

If you manufacture drugs in China — or you plan to — you need to master China’s new GMPs. China adopted updated GMP regulations in 2011 — effective immediately for new plants and no later than 2015 for existing facilities.

Order Today

Some key differences between China and the US and EU:

A plant’s certification to operate following inspection in China is valid for only 5 years.
China spells out specific education and professional requirements for quality directors, production managers and authorized persons.
The quality department is to be completely autonomous under Chinese GMPs.
China has specific requirements for the locations of plants relative to the local environment to address Chinese pollution concerns.

The revisions also make significant changes from prior Chinese GMPs, including:

New requirements for documents, such as SOPs, not addressed before
Adoption of ICH-style risk-management guidance for creating quality systems
New requirements for CAPA
New standards for sterile production that match EU requirements

Only one guide aims specifically to help non-Chinese drug manufacturers get into compliance with China’s GMPs. By special arrangement, that guide is now available to FDAnews clients.

Based in Nanjing, Access China Management Consulting Ltd. specializes in helping foreign firms navigate the often-baffling Chinese drug market.

The new Chinese rules run 14 chapters and 313 articles. Latest Guide to Chinese Pharmaceutical GMP Regulations summarizes and explains them in an easy-to-understand digest covering all the provisions you need to be aware of.

China’s pharmaceutical market is projected to become the world’s second-largest in 2015. In 2015, where do you want to be? If you answered “China,” order your copies of Latest Guide to Chinese Pharmaceutical GMP Regulations now.

Buy Now
Latest Guide to Chinese Pharmaceutical GMP Regulations is available in pdf format only (7 chapters, 136pp.) for $750. Act now: place your order here.

Your purchase is nonrefundable. All sales are final.

Shopping Cart

Your shopping cart is empty

Resource Center

Tenth Annual Medical Device Quality Congress
From Risk Management to Postmarket Surveillance
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today. Read More
Conducting Bulletproof CAPA Investigations — ADVANCED
Understanding Advanced Critical Thinking Skills and Innovative Techniques to Improve the Quality of Investigations and Understanding the Root Cause
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today. Read More
Surviving an FDA Inspection
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not! Read More

Product Details

Latest Guide to Chinese Pharmaceutical GMP Regulations

PDF Version